Description
GENOLAX-OD 1.2 is a therapeutic medication that contains Mesalamine (1200mg), a non-steroidal anti-inflammatory drug (NSAID) specifically formulated for the treatment and management of ulcerative colitis and other inflammatory bowel diseases (IBD). It works by reducing inflammation in the lining of the intestines, helping to alleviate symptoms such as diarrhea, rectal bleeding, and abdominal cramps.
Mesalamine (1200mg): Mesalamine is the active ingredient in GENOLAX-OD 1.2, which acts directly on the intestinal lining to reduce inflammation. This helps to control flare-ups and maintain remission in patients with ulcerative colitis, Crohn’s disease, or other IBD conditions. The controlled-release formulation ensures that the medication is released gradually, providing consistent therapeutic levels and minimizing side effects.
GENOLAX-OD 1.2 is used for both acute flare-ups and maintenance therapy in patients with IBD, helping to improve intestinal health, reduce inflammation, and prevent recurrence of symptoms. It is typically prescribed for long-term use, under medical supervision, to ensure optimal management of the condition and improve the quality of life for patients.
